ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 159 filers reported holding ANIKA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $291,000 | -58.6% | 8,128 | -50.8% | 0.02% | -56.9% |
| Q3 2021 | $703,000 | -0.8% | 16,509 | +0.8% | 0.05% | +8.5% |
| Q2 2021 | $709,000 | +1.3% | 16,381 | -4.6% | 0.05% | -6.0% |
| Q1 2021 | $700,000 | +125.1% | 17,164 | +174.5% | 0.05% | +400.0% |
| Q1 2018 | $311,000 | -51.1% | 6,252 | -47.0% | 0.01% | -44.4% |
| Q4 2017 | $636,000 | -19.4% | 11,800 | -13.2% | 0.02% | -30.8% |
| Q3 2017 | $789,000 | +17.6% | 13,600 | 0.0% | 0.03% | -3.7% |
| Q2 2017 | $671,000 | -9.7% | 13,600 | -20.5% | 0.03% | -30.8% |
| Q1 2017 | $743,000 | -32.3% | 17,107 | -23.6% | 0.04% | -45.8% |
| Q4 2016 | $1,097,000 | +1.5% | 22,400 | -0.9% | 0.07% | +14.3% |
| Q3 2016 | $1,081,000 | -10.8% | 22,600 | 0.0% | 0.06% | -34.4% |
| Q2 2016 | $1,212,000 | +25.2% | 22,600 | -4.1% | 0.10% | +317.4% |
| Q1 2014 | $968,000 | +75.0% | 23,557 | +62.5% | 0.02% | -65.7% |
| Q4 2013 | $553,000 | -63.3% | 14,501 | -77.0% | 0.07% | +63.4% |
| Q3 2013 | $1,508,000 | – | 62,918 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |